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Abstract 
Background: Direct cloning combined with heterologous expression of a secondary metabolite biosynthetic gene 
cluster has become a useful strategy for production improvement and pathway modification of potentially valuable 
natural products present at minute quantities in original isolates of actinomycetes. However, precise cloning and effi‑
cient overexpression of an entire biosynthetic gene cluster remains challenging due to the ineffectiveness of current 
genetic systems in manipulating large‑sized gene clusters for heterologous as well as homologous expression.
Results: A versatile Escherichia coli‑Streptomyces shuttle bacterial artificial chromosomal (BAC) conjugation vector, 
pSBAC, was used along with a cluster tandem integration approach to carry out homologous and heterologous over‑
expression of a large 80‑kb polyketide biosynthetic pathway gene cluster of tautomycetin (TMC), which is a protein 
phosphatase PP1/PP2A inhibitor and T cell‑specific immunosuppressant. Unique XbaI restriction sites were precisely 
inserted at both border regions of the TMC biosynthetic gene cluster within the chromosome of TMC‑producing 
Streptomyces sp. CK4412, followed by site‑specific recombination of pSBAC into the flanking region of the TMC gene 
cluster. The entire TMC gene cluster was then rescued as a single giant recombinant pSBAC by XbaI digestion of the 
chromosomal DNA as well as subsequent self‑ligation. Next, the recombinant pSBAC construct containing the entire 
TMC cluster in E. coli was directly conjugated into model Streptomyces strains, resulting in rapid and enhanced TMC 
production. Moreover, introduction of the TMC cluster‑containing pSBAC into wild‑type Streptomyces sp. CK4412 as 
well as a recombinant S. coelicolor strain resulted in a chromosomal tandem repeat of the entire TMC cluster with 
14‑fold and 5.4‑fold enhanced TMC productivities, respectively.
Conclusions: The 80‑kb TMC biosynthetic gene cluster was isolated in a single integration vector, pSBAC. Introduc‑
tion of TMC biosynthetic gene cluster in TMC non‑producing strains has resulted in similar amount of TMC production 
yield. Moreover, over‑expression of TMC biosynthetic gene cluster in original producing strain and recombinant S. 
coelicolor dramatically increased TMC production. Thus, this strategy can be employed to develop a custom overex‑
pression scheme of entire metabolite pathway clusters present in actinomycetes.
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Background
Microbial natural products are a major resource for drug 
discovery and development programs mainly due to their 
superior structural diversity and complexity [1]. Isolation 
and characterization of the natural products of biosyn-
thetic gene clusters have accelerated our understanding 
of the molecular mechanisms driving natural product 
biosynthesis and even guided the rational redesign of 
natural products through biosynthetic gene manipulation 
[2]. Since most microbial biosynthetic genes are clustered 
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within chromosomes, identification of the entire biosyn-
thetic gene cluster is relatively straightforward. Unfortu-
nately, some of these biosynthetic genes are derived from 
non-culturable or not amenable to genetic manipulation 
microorganisms and thus do not easily express the target 
compounds [3]. To bypass such intrinsic limitations and 
achieve functional expression of uncharacterized poten-
tially-valuable natural product biosynthetic pathways, a 
relatively well-characterized heterologous host should be 
utilized [4, 5]. Recent genome mining approaches have 
also identified a significant number of metabolite biosyn-
thetic gene clusters, some of which must be expressed in 
a heterologous host. Synthetic biology techniques have 
also made it possible to produce novel and/or improved 
natural products through reconstitution of biosynthetic 
gene clusters in an appropriate host system [3, 6–8].
Since the gene clusters responsible for the biosynthesis 
of microbial secondary metabolites are typically as large 
as 100 kb, appropriate vector systems capable of cloning 
an entire gene cluster as well as transferring these genetic 
segments between different hosts are necessary. Captur-
ing an entire biosynthetic gene cluster in a single E. coli 
clone can facilitate the genetic manipulation of second-
ary metabolite biosynthetic pathways using the PCR-tar-
geted gene replacement method [9–11]. Recently, a new 
E. coli-Streptomyces shuttle bacterial artificial chromo-
somal (BAC) vector system, pSBAC, which conveniently 
switches single-copy to high-copy replication in E. coli 
as well as utilizes the phage ΦBT1 attP-int site-specific 
integration system, was successfully used for the heter-
ologous expression of a meridamycin (mer) biosynthe-
sis gene cluster in S. lividans [12]. Specifically, to clone 
and express the entire mer cluster, a total genomic DNA 
library was first constructed through ligation of EcoRI-
digested pSBAC and MfeI-digested total genomic DNA, 
followed by intergeneric conjugation of the mer cluster 
containing pSBAC into S. lividans [12]. In this case, MfeI 
sites were present just outside of the mer cluster, and the 
large DNA fragment digested in the CHEF gel was also 
directly ligated with the MfeI-compatible EcoRI-digested 
pSBAC [12]. Therefore, it is more desirable to develop 
a general cloning strategy to quickly capture an entire 
biosynthetic gene cassette without depending on endog-
enous restriction sites in the cluster or a large DNA frag-
ment ligation process.
The plasmid rescue method is a technique for cloning 
and identifying the region of a locus adjacent to where 
an exogenous DNA fragment is inserted in the chro-
mosome [13–15]. Based on the capability of pSBAC to 
accommodate large DNA fragments, the recombinant 
pSBAC rescue method was carried out to precisely clone 
a large (approximately 80  kb) polyketide biosynthetic 
gene cluster for tautomycetin (TMC), which is a protein 
phosphatase PP1/PP2A inhibitor and T-cell-specific 
immunosuppressant [16–18]. Unique XbaI restriction 
sites were first inserted at both border regions of the 
TMC biosynthetic gene cluster within the chromosome 
of TMC-producing Streptomyces sp. CK4412, followed 
by site-specific recombination of pSBAC into the flanking 
region of the TMC gene cluster. Moreover, introduction 
of the TMC cluster-containing pSBAC into wild-type 
Streptomyces sp. CK4412 as well as a recombinant S. coe-
licolor strain resulted in a chromosomal tandem repeat 
of the entire TMC cluster with 40-fold enhanced TMC 
productivities. This strategy consisting of site-specific 
restriction site insertion, recombinant pSBAC plasmid 
rescue, intergeneric conjugation, and cluster tandem 
repeat introduction can be employed to develop a cus-
tom overexpression scheme of entire metabolite pathway 
clusters present in actinomycetes (Additional file 1: Table 
S1).
Results
PCR‑targeting of unique restriction enzyme sites 
into borders of TMC gene cluster
An E. coli-Streptomyces BAC conjugation vector, pSBAC 
(Fig.  1), has been successfully applied for heterologous 
Fig. 1 Map of pSBAC. Essential components of the vector are indi‑
cated. Ori2 and oriV, replication origins; SopA‑C, partitioning system; 
aacIII(IV), apramycin resistance gene; oriT, origin of transfer; ΦBT1 
attP‑int, integration system; Unique restriction enzyme recognition 
sites, BamHI, HindIII, and EcoRI
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expression of the entire meridamycin (mer) biosynthetic 
gene cluster [12]. The entire mer gene cluster (~95  kb) 
could be captured in a single pSBAC clone by straightfor-
ward restriction enzyme digestion due to the presence of 
unique restriction enzyme MfeI sites in border regions of 
the mer biosynthetic gene cluster. In contrast, most sec-
ondary metabolite biosynthetic gene clusters such as the 
TMC gene cluster do not possess unique restriction sites 
in border regions (Fig. 2a). To apply the pSBAC cloning 
system to metabolite gene clusters lacking unique restric-
tion enzyme sites in their border regions, we inserted 
unique XbaI restriction enzyme sites into border regions 
of the TMC biosynthetic gene cluster in the Streptomyces 
sp. CK4412 chromosome using PCR-targeted gene inser-
tion. For this, two DNA fragments, each containing a 
selection marker, oriT, and XbaI resctiction enzyme site, 
were synthesized and precisely inserted into TMC bor-
der-containing cosmids, pTMC2982 and pTMC2290, in 
E. coli. The modified cosmids were then conjugated into 
Streptomyces CK4412, followed by target sequence-spe-
cific recombination at the borders of the TMC gene clus-
ter (Fig.  2b). The resulting ex-conjugants were isolated 
based on the selection markers and confirmed to possess 
the correct XbaI insertions by PCR analysis and sequenc-
ing (Additional file 2: Fig. S1).
Precise cloning of entire TMC biosynthetic gene cluster as a 
single giant recombinant pSBAC
The typical cloning method for large-sized DNA frag-
ment isolation requires extra care so as to avoid unin-
tended DNA fragmentation. Alternatively, the in  vivo 
plasmid rescue method can be used to isolate a particular 
chromosomal locus through recovery of adjacent DNA 
sequences [13–15]. Here, we applied the plasmid rescue 
technique using pSBAC in order to clone a large DNA 
fragment containing the TMC biosynthetic gene clus-
ter. A 3480-bp tmcI DNA fragment containing the gene 
at the left end of the cluster was first cloned into attP-
int deleted pSBAC plasmid (named pSATNI), followed 
by conjugation into Streptomyces sp. CK4412. The pres-
ence of the tmcI fragment allowed pSATNI vector to 
integrate into the left site of the TMC biosynthetic gene 
cluster as a result of targeted homologous recombina-
tion (Fig.  2c). Genomic DNA from kanamycin-resistant 
conjugants was isolated and digested by XbaI restriction 
enzyme. XbaI-digested total chromosomal DNA frac-
tions were self-ligated, followed by transformation into E. 
coli cells. DNA was then isolated from the transformants 
and analyzed by PCR, restriction enzyme digestion, and 
sequencing. Analysis revealed that the entire TMC bio-
synthetic gene cluster was successfully cloned as a single 
recombinant pSBAC vector (Additional file  3: Fig. S2). 
Finally, the DNA fragment containing ФBT1 attP-int was 
re-introduced into the rescued recombinant pSBAC vec-
tor and named pMMBL101 (Fig. 2d).
Heterologous expression of TMC biosynthetic gene cluster 
in Streptomyces strains
The newly formed pMMBL101 vector was conjugated 
into Streptomyces strains, including S. coelicolor M145 
and S. lividans TK21. Both S. lividans and S. coelicolor 
have been successfully used for the heterologous expres-
sion of various Streptomyces secondary metabolite bio-
synthetic gene clusters. pMMBL101 was first transferred 
into S. lividans TK21 via conjugation, and the resulting 
transformant strain containing the tmc gene cluster was 
named S. lividans TMC002 (Fig.  3a). pMMBL101 was 
also introduced into S. coelicolor M145 by PEG-mediated 
transformation, resulting in S. coelicolor TMC003. These 
two recombinant strains along with wild-type strain were 
cultured in R5 media for 5 days. Although TMC was not 
detected in the 3-day wild-type culture, both S. lividans 
TMC002 and S. coelicolor TMC003 showed TMC pro-
duction by day 3 (Fig. 3b). After 5 days of culture, TMC 
production levels in TMC002 and TMC003 were about 
1.3-fold (4.05  mg/L) and 1.26-fold (3.91  mg/L) higher 
than that in wild-type (3.1 mg/L), respectively (Fig. 3b). 
These results reveal that the pSBAC-driven heterologous 
expression of an entire TMC biosynthetic gene cluster 
resulted in rapid and enhanced TMC production.
Homologous or heterologous tandem integration of entire 
TMC cluster
To further stimulate TMC productivity, an addi-
tional copy of the TMC cluster was introduced into the 
TMC single copy-containing wild-type Streptomyces 
sp. CK4412 and S. coelicolor TMC003 strains (Fig.  4). 
pMMBL101 was first introduced into Streptomyces sp. 
CK4412 by conjugation. Among the resulting ex-con-
jugants, four were randomly selected for further analy-
sis by PCR amplification of attP-int-amplifying primer 
sets. PCR analysis showed that pMMBL101 integrated 
adjacent to the original tmc cluster in three of the four 
selected strains (named CK4412-TMC001), whereas 
pMMBL101 inserted into the attB site of the Streptomy-
ces sp. CK4412 chromosome in only one strain. Chro-
mosomal integration of pMMBL101 was confirmed by 
rapid draft genome sequencing. Total length of complete 
genome sequence was 9,803,578 bp. G + C content was 
determined to be 71.27  %. From the gene prediction 
results, 9141 CDSs were identified. The contig arrange-
ments show that the pSBAC was inserted between two 
TMC biosynthetic gene clusters (Additional file  4: Fig.
S3). Streptomyces sp. CK4412-TMC001 cultured in R5 
media for 5 days showed a 14-fold increase in TMC pro-
duction (34.47  mg/L) compared to the parental strain 
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Fig. 2 Schematic description of pMMBL101 construction. TmcA and tmcB, type I polyketide synthase; tmcC‑I and tmcP‑Q, diakylmaleic anhydride 
moiety processing; tmcJ and tmcK, decarboxylase; tmcL, crotonyl‑CoA reductase; tmcM, dehydratase; tmcN and tmcT, pathway‑specific regulator; 
tmcO, thioesterase; tmcR, cytochrome P450; tmcS, transporter. a Tautomycetin structure and its biosynthetic gene cluster organization in Strepto-
myces sp. CK4412. b Insertion of XbaI recognition sequences into both flanking regions of tmc cluster via PCR‑targeting system. c Modification of 
pSBAC and introduction of modified pSBAC (pSATNI) into Streptomyces sp. CK4412 chromosome. d XbaI digestion of CK4412 chromosome and 
self‑ligation of digested chromosomal DNA to generate pTMC. After construction of pTMC, attP‑int gene was inserted into AvrII recognition site of 
pTMC to generate pMMBL101
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(2.47  mg/L) (Fig.  5). Comparative qRT-PCR results also 
confirmed that transcription of three biosynthetic genes 
(tmcB, tmcC, and tmcJ) as well as two pathway-specific 
regulatory genes (tmcN and tmcT) was significantly stim-
ulated in CK4412-TMC001 (Fig. 6). This implies that the 
presence of an additional copy of the entire TMC bio-
synthetic gene cluster was responsible for the increased 
transcription of TMC biosynthetic genes. To further ver-
ify introduction of a tandem repeat of the TMC cluster 
into a heterologous host, an apramycin-resistant gene of 
pMMBL101 was replaced by a spectinomycin/streptomy-
cin-resistant gene to generate pMMBL102, followed by 
introduction into S. coelicolor TMC003 (named S. coeli-
color TMC004). Similar to CK4412-TMC001 containing a 
tandem repeat of the TMC cluster, S. coelicolor TMC004 
cultured in R5 media for 5  days also showed a 5.4-fold 
increase in TMC production (13.31  mg/L) compared 
to the original TMC-producing strain, S. sp. CK4412 
Fig. 3 a Construction of S. lividans TMC002 and S. coelicolor TMC003 by E. coli‑Streptomyces conjugation system. b Comparison of TMC production 
yields on 3 and 5 day in CK4412, S. lividans TMC002 and S. coelicolor TMC003. White CK4412, Gray S. lividans TMC002, Black S. coelicolor TMC003
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(2.47 mg/L) (Fig. 5), suggesting that pSBAC-driven intro-
duction of a cluster tandem repeat was equally effective 
in both homologous and heterologous host systems.
Discussion
Isolation and characterization of a secondary metabo-
lite pathway gene cluster in Streptomyces species can 
elucidate its molecular biosynthetic and regulatory 
mechanisms. Here, a secondary metabolite produced by 
Streptomyces sp. CK4412, originally isolated from Jeju 
Island, Korea, was identified as an activated T cell-spe-
cific immunosuppressive compound with novel pharma-
cological activities in both in  vivo and in  vitro studies, 
and its chemical structure was shown to be identical to 
that of tautomycetin (TMC), an antifungal compound 
with a structurally-unique ester bond linkage between its 
terminal cyclic anhydride moiety and linear polyketide 
chain [19]. TMC is believed to specifically block tyros-
ine phosphorylation of intracellular signal mediators 
downstream of Src tyrosine kinases in a T cell-specific 
manner via selective inhibition of protein phosphatase 
1 (PP1) and PP2A [18, 20, 21]. However, the Src homol-
ogy-2 domain containing protein tyrosine phosphatase-2 
(SHP2) was also recently shown to be a putative target for 
the immunosuppressive activity of TMC [22]. Moreover, 
Fig. 4 Construction of Streptomyces sp. CK4412‑TMC001 and S. coelicolor TMC004
Fig. 5 TMC production comparison of heterologous and homolo‑
gous expression strains
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TMC has been reported to inhibit growth of colorectal 
cancer cells, implying it is a potentially-valuable natu-
ral product with multiple medically relevant functions, 
including anti-fungal, immunosuppressive, and anti-can-
cer activities. Although the entire TMC biosynthetic and 
regulatory pathway gene clusters have been isolated from 
Streptomyces sp. CK4412 and characterized, pharmacoki-
netic application of TMC as a novel bioactive compound 
remains insufficient due to lack of knowledge of how its 
multiple biological activities correlate to specific moie-
ties of its structure as well as its intrinsic low-level titer 
observed in wild-type.
Although heterologous expression of a metabolic 
pathway gene cluster is an attractive alternative to con-
ventional cell culture, cloning and stable expression of 
large-sized DNA have become challenges to developing 
a heterologous expression system for Streptomyces. A 
few recent reports have examined the overexpression of 
a secondary metabolite gene cluster in Streptomyces spe-
cies. Specifically, a site-specific recombination system 
was engineered to catalyze tandem amplification of a 
35-kb actinorhodin biosynthetic gene cluster in S. coeli-
color [23]. In this case, the oriT-like recombination sites 
RsA and RsB as well as site-specific relaxase gene zouA 
were inserted into the S. coelicolor genome flanking an 
actinorhodin biosynthetic gene cluster. Recombination 
between RsA and RsB was followed by zouA-dependent 
DNA amplification, resulting in an average of nine tan-
dem repeats of the actinorhodin gene cluster per genome 
as well as a 20-fold increase in actinorhodin production 
[23]. Unfortunately, the actinorhodin cluster in a 110-kb 
AUD (amplifiable units of DNA) failed to overproduce 
actinorhodin, implying this approach may not be appli-
cable to overexpression of a large-sized gene cluster in 
Streptomyces. Another study directly cloned a gene clus-
ter via transformation-associated recombination (TAR) 
in yeast as an alternative approach [24]. Further, a 67-kb 
cryptic non-ribosomal peptide synthase biosynthetic 
gene cluster identified by genome mining of the marine 
actinomycete Saccharomonospora sp. CNQ-490 was 
cloned and expressed in S. coelicolor, resulting in produc-
tion of taromycin A as a new antibiotic related to dap-
tomycin [24]. Although a TAR-based system might be 
suitable for cloning and expression of a large cryptic gene 
cluster screened from actinomycetes genome mining, 
TAR-based cloning must be performed in yeast before 
intergeneric conjugation into Streptomyces. In addition, a 
tandem repeat of the target gene cluster in a heterologous 
host is not applicable in a TAR-based expression system.
pSBAC was previously applied for cloning a 95-kb 
Streptomyces meridamycin biosynthetic gene cluster into 
a heterologous S. coelicolor host [12]. Although unique 
restriction enzyme MfeI sites were absent inside the mer 
cluster, they were present just adjacent to the mer cluster in 
the chromosome. However, most Streptomyces secondary 
metabolite gene clusters, including the tmc cluster, have 
no unique restriction enzyme sites in their border regions, 
which make the pSBAC system less attractive for heter-
ologous Streptomyces expression. To overcome the limited 
applicability of the pSBAC-based heterologous expression 
system, we developed a general method for the site-specific 
introduction of unique restriction enzyme XbaI sites into 
border regions of the tmc biosynthetic gene cluster within 
the Streptomyces sp. CK4412 chromosome, as illustrated 
in Fig. 2. Using this approach, we demonstrated that any 
restriction enzyme site could be introduced at any specific 
location of the chromosome. Cloning of a large-sized DNA 
fragment is challenging due to its in vitro physical instabil-
ity. An attractive alternative to conventional in vitro clon-
ing is in vivo plasmid rescue. Instead of cloning the entire 
tmc gene cluster into the pSBAC vector in  vitro, a small 
DNA fragment containing the flanking region of the tmc 
gene cluster, tmcI, was cloned into pSBAC and underwent 
in  vivo homologous recombination. Simple XbaI diges-
tion of total chromosomal DNA followed by self-ligation, 
E. coli transformation, and apramycin selection were per-
formed to recover the giant recombinant pSBAC vector 
containing the entire tmc biosynthetic gene cluster. Finally, 
Fig. 6 Transcripts analysis of tmc‑overexpressed CK4412 (CK4412‑
TMC001). The RNA sample was taken day 5. Three biosynthetic genes 
(tmcB, mcC, and tmcJ) and two pathway specific regulatory genes 
(tmcN and tmcT) were amplified. Each gene was amplified in dupli‑
cate. Error rates were calculated by standard deviation. White square 
CK4412 WT; black square CK4412‑TMC001
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tmc-containing pSBAC in recombinant E. coli was success-
fully conjugated or transformed into Streptomyces species, 
implying that the described pSBAC approach could be 
generally applied to heterologous Streptomyces expression 
and synthetic biology. Further, genetic modification of the 
cluster, including target promoter optimization or spe-
cific gene manipulation, could be easily carried out in E. 
coli. Another advantage of the giant recombinant pSBAC 
system is the ability to re-introduce the entire gene cluster 
into both the original host chromosome as well as single 
cluster-containing recombinant host, resulting in a stable 
tandem repeat of the entire biosynthetic gene cluster. Two 
copies of the tmc gene cluster exhibited a 14-fold increase 
in TMC production, implying this pSBAC-driven tandem 
repeat approach is very effective for both homologous and 
heterologous overexpression [25, 26]. In conclusion, the 
Streptomyces pSBAC-driven precise cloning and tandem 
integration approach described here can be applied to the 
versatile overexpression of a large secondary metabolite 
gene clusters in actinomycetes, including novel cryptic 
clusters identified by genome mining [27].
Conclusions
Although actinomycetes continue to be a rich source 
of valuable secondary metabolites, their wild-type 
production levels are usually too low to be useful in the 
field of drug development. Here, we demonstrated an 
attractive genetic system for the efficient homologous 
and heterologous overexpression of a target cluster in 
Streptomyces species. Site-specific chromosomal integra-
tion of unique restriction sites as well as in vivo plasmid 
rescue of a Streptomyces bacterial artificial chromosome 
vector, pSBAC, containing a large biosynthetic gene clus-
ter were performed for precise cloning and expression 
of the target cluster in a surrogate Streptomyces host. 
Re-introduction of a giant recombinant pSBAC vector 
into the chromosome of the Streptomyces host contain-
ing a single copy cluster resulted in a chromosomal tan-
dem repeat of the entire TMC cluster with significantly 
enhanced TMC productivities. This approach demon-
strates a platform technology for the precise cloning and 
functional overexpression of the entire biosynthetic gene 
cluster of any potentially-valuable low-titer metabolite in 
actinomycetes.
Methods
Bacterial strains and culture media
Various strains and plasmids used in this study are sum-
marized in Table 1. E. coli strains were cultured at 37 °C 
in Luria–Bertani (LB) broth or on Luria–Bertani agar 
Table 1 Bacterial strains and plasmids used in this study
Strain/plasmid Relevant characteristics Source/reference
Plasmid
 pSBAC aacIII(IV), oriT, attP‑int, backbone of pCC1BAC [12]
 pSATNI Modified pSBAC which deleted attP‑int and inserted KanR and tmcI fragment This work
 pTMC pSATNI with 85 kb DNA insert containing whole tmc gene cluster This work
 pMMBL101 pTMC with attP‑int This work
 pMMBL102 pMMBL101 which replaced AprR into SpeR This work
E. coli
 EPI300 F‑ mcrA‑D(mrr‑hsdRMS‑mcrBC) trfA host for cloning and amplification of various BAC vectors and constructs 
derived from it
Epicenter
 S17‑1 E. coli host for transferring various plasmids into Streptomyces via conjugation
 ET12567/
pUZ8002
E. coli host for transferring various plasmids into Streptomyces via conjugation
Streptomyces sp.
 CK4412 Original TMC‑producing strain [17]
 CK4412‑2XB CK4412 with pSATNI and XbaI recognition sequences in both flanking region of TMC biosynthetic gene 
cluster
This work
 TMC001 pMMBL101‑containing CK4412 This work
Streptomyces lividans
 TK21 Non TMC‑producing strain
 TMC002 TK21 with pMMBL101 This work
Streptomyces coelicolor
 M145 Non TMC‑producing strain
 TMC003 M145 with pMMBL101 This work
 TMC004 pMMBL102‑containing S. coelicolor TMC003 This work
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supplemented with appropriate antibiotics [28]. Strepto-
myces sp. CK4412 was used as an original TMC-produc-
ing stain [17]. For production of TMC, all Streptomyces 
strains were grown at 28 °C in TSB media for 2 days and 
then cultured for 7 days in R5 media [17]. Modified ISP4 
medium was used for conjugation while R2YE medium 
was used for PEG-mediated transformation.
Insertion of unique XbaI recognition sequences in both 
flanking regions of tautomycetin biosynthetic gene cluster
To isolate the TMC biosynthetic gene cluster, unique 
XbaI recognition sequences were inserted into both 
flanking regions of the TMC biosynthetic gene clus-
ter using a PCR-targeted gene disruption system [29]. 
Briefly, an apramycin resistance gene (aac(3)IV)/oriT 
cassette and spectinomycin resistance gene (aadA)/oriT 
cassette were used to insert XbaI recognition sequences 
into both flanking regions. These cassettes were ampli-
fied from pIJ773 and pIJ778 using XbaI recognition 
sequence-containing primers and then introduced into 
E. coli BW25113/pIJ790 containing pTMC2982 or 
pTMC2290, resulting in pTMC2982::aac(3)IV/oriT and 
pTMC2290::aad/oriT, respectively. Insertion of XbaI 
recognition sequences was confirmed by PCR applied to 
mutated pTMC2982 and pTMC2290. The mutated cos-
mids pTMC2982::aac(3)IV/oriT and pTMC2290::aad/
oriT were then introduced into Streptomyce sp. CK4412 
by conjugation with E. coli ET12567/pUZ8002. Conjuga-
tion experiments were performed as described previously 
[30]. Conjugation was repeated using the isolated Strep-
tomyces sp. CK4412::aac(3)IV strains in order to insert 
the XbaI recognition sequence into the opposite flanking 
region. The desired double cross-over mutants, selected 
by their apramycin-resistant (or spectinomycin-resist-
ant) and kanamycin-sensitive phenotypes, were isolated. 
Their genotypes were verified using PCR.
Isolation of entire tautomycetin biosynthetic gene cluster 
into pSBAC
To isolate the entire TMC biosynthetic gene cluster from 
the chromosome by XbaI digestion and ligation, attP-
int containing XbaI recognition sequences was removed 
from pSBAC by AvrII digestion and ligation. To select 
the right colony, a kanamycin resistance gene was ligated 
into BamHI-EcoRI-digested pSBAC. To integrate the 
modified pSBAC into the desired location by homolo-
gous recombination, a 3480-bp DNA fragment includ-
ing a part of tmcI (tmcI′) was amplified by PCR using 
the pTMC2982 cosmid as a template. The amplified PCR 
products were then ligated into a RBC T&A cloning vec-
tor. The ligated vector was completely sequenced in order 
to ensure its integrity (Macrogen, Korea). The tmcI’ frag-
ment, digested using BamHI and HindIII, was cloned into 
modified pSBAC to generate pSATNI. Conjugation was 
performed to integrate pSATNI into the chromosome by 
homologous recombination. The desired mutant (named 
CK4412-2XB) was selected on kanamycin-included MS 
agar medium, and its genotypes were verified using PCR.
CK4412-2XB strain was cultured at 28 °C in TSB media 
for 2 days, and preparation of genomic DNA of CK4412-
2XB was carried out using a Wizard® genomic DNA 
purification kit (Promega). Genomic DNA was digested 
by restriction enzyme XbaI, purified, and concentrated 
by ethanol precipitation before self-ligation using T4 
ligase (TaKaRa). After desalting, the ligation mixture was 
used for electroporation of E. coli EPI300. Recombinant 
colonies were selected onto apramycin- and kanamycin-
containing LB medium. Plasmids were isolated by alkali 
denaturation and screened by PCR using randomly 
selected primers within the tmc cluster to identify pTMC.
A 2-kb DNA fragment containing the attP-int of ΦBT1 
was amplified by PCR using pSBAC as a template and 
ligated into RBC T&A cloning vector. The ligated vector 
was completely sequenced to ensure integrity. The attP-
int, digested using AvrII, was cloned into pTMC to gener-
ate pMMBL101.
HPLC quantification and antifungal bioassay for TMC
Extraction of TMC and HPLC analysis were carried out 
according to previously reported methods [30]. Briefly, 
culture broth was extracted twice using an equal volume 
of ethyl acetate, followed by concentration using a rotary 
evaporator. The final extracts were dissolved in methanol. 
Analytical HPLC was carried out on a Grace C18 4-μm 
column at a flow rate of 1 ml/min with UV detection at 
273 nm.
Antifungal bioassay was performed for qualitative 
analysis of TMC production yield of tmc-containing het-
erologous hosts. Evaluation of TMC production was car-
ried out by the paper disc diffusion method. Aspergillus 
niger stock (1 ml) was inoculated onto ME agar medium, 
after which extract-soaked discs were placed onto the 
prepared medium. The plates were incubated at 30 °C for 
2 days.
Isolation of total RNA and gene expression analysis 
by RT‑PCR
For RNA preparation, CK4412, CK4412-TMC001, S. liv-
idans TMC002, S. coelicolor TMC003, S. coelicolor TMC004 
were grown for 5 days in R5 medium, after which samples 
were taken at 120 h. Mycelia were harvested by centrifuga-
tion and stored in a −40 °C deep freezer after washing twice 
with distilled water. RNA preparation and RT-PCR were 
carried out according to previously reported methods [25]. 
Briefly, after the frozen mycelia were broken by shearing in 
a mortar, total RNA was isolated by using RNeasy mini kit 
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[QIAGEN, Germany]. DNase-I treated RNA, AVM Reverse 
Transcriptase XL [TaKaRa, Japan] and random hexamers 
was used for cDNA synthesis. HrdB gene was used as inter-
nal control. Transcripts from three biosynthetic genes such 
as tmcB, tmcC, and tmcJ and two regulatory genes, tmcN 
and tmcT, were analyzed after 30 PCR cycles. Primers used 
for RT-PCR were previously reported [25].
Replacement of apramycin‑resistant gene 
by spectinomycin‑resistant gene and introduction 
into tmc‑containing Strains
To introduce the tmc cluster into S. coelicolor TMC003, 
the apramycin-resistant gene of pMMBL101 was 
replaced by a spectinomycin-resistant gene (named 
pMMBL102) using a Quick & Easy BAC modifica-
tion kit (GeneBridges). The Red/ET plasmid was intro-
duced into pMMBL101-containing E. coli EPI300, after 
which BAC modification was performed according 
to the manufacturer’s guide using PCR to amplify the 
spectinomycin-resistant gene in the aprR-homologous 
region. Transformants were selected on spectinomycin-
containing LB medium and confirmed by PCR. After 
pMMBL102 was transformed into E. coli S17-1, it was 
introduced into S. coelicolor TMC003 by conjugation.
Rapid genome sequencing of Streptomyces sp. 
CK4412‑TMC001
Genomic DNA of Streptomyces sp. CK4412-TMC001 was 
prepared from 3-days culture with a Wizard® Genome 
DNA Purification Kit (Promega). The genomic DNA 
was fragmented by dsDNA fragmentase to make proper 
size for library construction. Resulting DNA fragments 
was processed to Illumine Nextera DNA sample prepa-
ration kit (Illumina, Inc., USA) following manufacturer’s 
instruction. Final library was quantified by Bioanalyzer 
2100 (Agilent, USA) and average library size was 300 bp.
The genomic library was sequenced by Illumina MiSeq 
(Illumina, Inc., USA). Generated paired-end sequencing 
reads (23,891,700 method reads) were assembled using CLC 
genomics workbench 6.0 (CLC bio, Denmark) and resulted 
in 253 contigs. The contigs and PCR-based long reads were 
combined through manual curation by using CodonCode 
Aligner 3.7.1 (CodonCode Corp., Dedham, MA, USA). The 
final plasmid sequence was corrected by remapping with 
raw reads to check errors and dubious regions.
The coding sequences (CDS) were predicted by Glim-
mer 3.02 [31]. tRNA were identified by tRNA-Scan-
SE [32], and rRNA were searched using HMMER with 
EzTaxon-e rRNA profiles [33, 34]. The predicted CDSs 
were compared to catalytic families (catFam) and NCBI 
COG by rpsBLAST and NCBI reference sequences (Ref-
Seq) and SEED databases by BLASTP for functional 
annotation [35–38].
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